Reglodi D - Search Results

1

The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney.

Horvath G, Opper B, Reglodi D. Horvath G, et al. Among authors: reglodi d. Int J Mol Sci. 2019 Oct 7;20(19):4944. doi: 10.3390/ijms20194944. Int J Mol Sci. 2019. PMID: 31591326 Free PMC article. Review.

2

Pituitary adenylate cyclase activating polypeptide is highly abundant in the nervous system of anoxia-tolerant turtle, Pseudemys scripta elegans.

Reglödi D, Somogyvári-Vigh A, Vígh J, Li M, Lengvári I, Arimura A. Reglödi D, et al. Peptides. 2001 Jun;22(6):873-8. doi: 10.1016/s0196-9781(01)00412-0. Peptides. 2001. PMID: 11390016

3

The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats.

Reglodi D, Kiss P, Tamás A, Lengvári I. Reglodi D, et al. Behav Brain Res. 2003 Mar 18;140(1-2):131-9. doi: 10.1016/s0166-4328(02)00289-9. Behav Brain Res. 2003. PMID: 12644286

4

The effect of PACAP on rhythmic melatonin release of avian pineals.

Csernus V, Józsa R, Reglodi D, Hollósy T, Somogyvári-Vigh A, Arimura A. Csernus V, et al. Among authors: reglodi d. Gen Comp Endocrinol. 2004 Jan 1;135(1):62-9. doi: 10.1016/s0016-6480(03)00284-3. Gen Comp Endocrinol. 2004. PMID: 14644645

5

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Reglodi D, et al. Behav Brain Res. 2004 May 5;151(1-2):303-12. doi: 10.1016/j.bbr.2003.09.007. Behav Brain Res. 2004. PMID: 15084446

6

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.

Reglodi D, Fábián Z, Tamás A, Lubics A, Szeberényi J, Alexy T, Tóth K, Márton Z, Borsiczky B, Rõth E, Szalontay L, Lengvári I. Reglodi D, et al. Regul Pept. 2004 Dec 15;123(1-3):51-9. doi: 10.1016/j.regpep.2004.05.012. Regul Pept. 2004. PMID: 15518893

7

Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.

Farkas O, Tamás A, Zsombok A, Reglodi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Farkas O, et al. Among authors: reglodi d. Regul Pept. 2004 Dec 15;123(1-3):69-75. doi: 10.1016/j.regpep.2004.05.014. Regul Pept. 2004. PMID: 15518895

8

Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats.

Reglodi D, Tamás A, Lubics A, Szalontay L, Lengvári I. Reglodi D, et al. Regul Pept. 2004 Dec 15;123(1-3):85-94. doi: 10.1016/j.regpep.2004.05.016. Regul Pept. 2004. PMID: 15518897

9

Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.

Tamás A, Gábriel R, Rácz B, Dénes V, Kiss P, Lubics A, Lengvári I, Reglodi D. Tamás A, et al. Among authors: reglodi d. Neurosci Lett. 2004 Nov 30;372(1-2):110-3. doi: 10.1016/j.neulet.2004.09.021. Neurosci Lett. 2004. PMID: 15531098

10

Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis.

Gasz B, Rácz B, Roth E, Borsiczky B, Ferencz A, Tamás A, Cserepes B, Lubics A, Gallyas F Jr, Tóth G, Lengvári I, Reglodi D. Gasz B, et al. Among authors: reglodi d. Peptides. 2006 Jan;27(1):87-94. doi: 10.1016/j.peptides.2005.06.022. Epub 2005 Aug 10. Peptides. 2006. PMID: 16095757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters